Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2762 |
|
Actual shortage: | 228 (8%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2524 (91%) | |
Discontinuation Reports |
256 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 253 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
13 (6%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-04-15 | 2022-01-28 | 137544 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153132 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153144 |
TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153162 |
ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2021-08-27 | 2022-01-28 | 144691 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151468 |
TEVA-QUININE | 200MG | CAPSULE | Resolved | 2021-12-17 | 2022-01-20 | 151462 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151456 |
TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-30 | 2022-01-20 | 146446 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-02 | 2022-01-20 | 145124 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151419 |
TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2021-06-24 | 2022-01-20 | 141489 |
TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152414 |
TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152411 |
TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2021-11-25 | 2022-01-07 | 149937 |
TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-11-18 | 2022-01-07 | 149609 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-11-11 | 2022-01-07 | 149105 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2021-10-21 | 2022-01-07 | 147702 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-08-24 | 2022-01-07 | 144497 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |